
NYXOAH SA
NYXH · NASDAQ
Updated at 2026-10-15 10:35:18
- Today's High
- $1.27
- Today’s Low
- $1.23
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.27
- Previous Close
- $1.25
- Volume
- 91.58K
- Market Cap
- $117.93M
- P/E Ratio
- --
- EPS
- $-2.16
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- MEDICAL DEVICES
- Headquarters
- RUE EDOUARD BELIN 12, MONT-SAINT-GUIBERT, BELGIUM, 1435
- Country
- BE
- Listing Date
- 2020-09-18
- Fiscal Year End
- December
- Shares Outstanding
- 100.07M
- CIK
- 0001857190
- Website
- www.nyxoah.com
Nyxoah is an innovative medical technology firm dedicated to advancing treatment options for obstructive sleep apnea (OSA) through its proprietary Genio system, which employs minimally invasive hypoglossal nerve stimulation. The company is committed to clinical validation and extensive research to enhance patient outcomes and quality of life for individuals affected by OSA. By prioritizing innovation in the sleep medicine domain and fostering strategic partnerships, Nyxoah is strategically positioned to leverage the growing demand for effective OSA treatments, indicating strong prospects for long-term growth within the healthcare industry.
Financial Metrics
Revenue
2026-06-30
$7.67M
2026-03-31
$7.36M
2025-12-31
$5.64M
2025-09-30
$1.97M
Operating Expenses
2026-06-30
$25.17M
2026-03-31
$25.95M
2025-12-31
$21.88M
2025-09-30
$25.38M
Net Income
2026-06-30
-$32.96M
2026-03-31
-$18.42M
2025-12-31
-$23.51M
2025-09-30
-$23.58M
Net Profit Margin
2026-06-30
-429.49%
2026-03-31
-250.22%
2025-12-31
-416.6%
2025-09-30
-1.19K%
Earnings Per Share
2026-06-30
$-0.67
2026-03-31
$-0.43
2025-12-31
$-0.59
2025-09-30
$-0.63
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$17.59M
2026-03-31
-$14.89M
2025-12-31
-$21.5M
2025-09-30
-$21.73M
Effective Tax Rate
2026-06-30
-1.46%
2026-03-31
-2.5%
2025-12-31
-3.95%
2025-09-30
1.21%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $7.67M | $7.36M | $5.64M | $1.97M |
| Operating Expenses | $25.17M | $25.95M | $21.88M | $25.38M |
| Net Income | -$32.96M | -$18.42M | -$23.51M | -$23.58M |
| Net Profit Margin | -429.49% | -250.22% | -416.6% | -1.19K% |
| Earnings Per Share | $-0.67 | $-0.43 | $-0.59 | $-0.63 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$17.59M | -$14.89M | -$21.5M | -$21.73M |
| Effective Tax Rate | -1.46% | -2.5% | -3.95% | 1.21% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.